No Data
No Data
Macquarie Initiates Privia Health(PRVA.US) With Buy Rating, Announces Target Price $25
Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m
Privia Health Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $28